Acutus Medical Inc. (AFIB) Social Stream



Acutus Medical Inc. (AFIB): $0.17

0.00 (-2.58%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

ACUTUS MEDICAL INC (AFIB) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AFIB.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-13 3 $19 $15 $17.333 $0.175 9804.57%
2021-11-12 3 $19 $10 $14.5 $0.175 8185.71%
2022-01-14 4 $3 $3 $3 $0.175 1614.29%
2022-06-24 4 $3 $1.5 $2.25 $0.175 1185.71%
2022-08-16 5 $3 $1.5 $2 $0.175 1042.86%
NA 1 $NA $NA $NA $0.175 NA%

The Trend in the Analyst Price Target


AFIB's average price target has moved down $18.67 over the prior 13 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

AFIB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 24 months, AFIB's average broker recommendation rating worsened by 0.83.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AFIB as an investment opportunity.

  • ACUTUS MEDICAL INC's upside potential (average analyst target price relative to current price) is greater than 1277.01% of all US stocks.
  • AFIB has a higher number of analysts covering the stock than 149.56% of all US stocks.
  • AFIB has a higher average analyst price target than 104.14% of Medical Equipment stocks.
  • ACUTUS MEDICAL INC's variance in analysts' estimates is lower than -459.53% of Medical Equipment stocks.

In the Medical Equipment industry, DRTS, BVS, and NPCE are the three stocks most similar to ACUTUS MEDICAL INC regarding the price target and analyst recommendation information presented here.

What is the outlook for AFIB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!